Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-10-01 | Phase3 Readout | — |
| 2026-11-22 | Phase3 Readout | — |
| 2026-12-01 | Phase2 Readout | — |
Active Clinical Trials (5)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07174076 | Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease | PHASE4 | Recruiting | 300 |
| NCT07135180 | Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups | OTHER | Active Not Recruiting | 200 |
| NCT07135193 | Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath... | OTHER | Active Not Recruiting | 12 |
| NCT06601283 | Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer | PHASE3 | Recruiting | 50 |
| NCT06598033 | Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer | PHASE3 | Recruiting | 50 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.